An indirect comparison of HbA1c treatment effect with albiglutide and exenatide 2.0 mg QW using the Bucher method by Martin AA, Parks D

“…In the absence of a head-to-head trial, these results can be used in pharmacoeconomic analysis and to inform health technology assessment and clinical decision making. …”
Get full text

Bayesian statistic methods and theri application in probabilistic simulation models by Orietta Zaniolo, Mario Eandi

“…Aim of this study is to outline an updated therapeutic and pharmacoeconomic profile of fluvastatin, particularly regarding extended-release (RP) 80 mg formulation.…”
Get full text

Clinicoeconomic effectiveness of using psychotherapy to treat patients with essential hypertension by Zh A Kalmataeva, A A Zholamanova

“…The decrease in BP and the average number of visits required to reach goal BP were estimated as a criterion for therapeutic effectiveness. A pharmacoeconomic analysis of antihypertensive therapy was made in each group. …”
Get full text

Moxifloxacina: profilo farmacologico, terapeutico e farmacoeconomico by Mario Eandi

“…The pharmacodynamics, pharmacokinetics and clinical results of moxifloxacin render it one of the most attractive options for the empirical treatment of upper and lower airways infections, more so since its pharmacoeconomic profile appears to be very convenient. …”
Get full text

Recombinant-activated factor VII in patients with uncontrolled bleeding: A retrospective observational analysis by Said D Abuhasna, Amer H Al Jundi, Hashem A Tarifi

“…Objective: The primary objective of this study was to assess the safety and effectiveness of factor VIIa (recombinant) on blood transfusion requirements and coagulation parameters when used in patients whose bleeding was uncorrected by other means. The pharmacoeconomic impact for any discrepancy from our protocol was evaluated. …”
Get full text

EVALUATION EFFICIENCY OF MODERN ANTIDEPRESSANTS BY MEANS OF QUANTATIVE PHARMACO-EEG by Oksana Kudelina, Dmitry Khloponin, Yury Maklyakov, Vladimir Zaika, Elena Gantsgorn

“…In this study, by means of quantitative pharmaco-EEG (QPEEG) was performed a comparative evaluation of pharmacological activity of valdoxan, fluoxetine and combination of fluoxetine with melaxen during rat's experimental depression (ED) and depressive disorder (DD) in patients. Pharmacoeconomic analysis was performed by the method of "cost/effectiveness". …”
Get full text

Clinical feasibility study of an immunotropic drug for treatment of complicated pyodermas by Roman A. Khmel’nitskij, Andrej V. Vislobokov

“…Based on the obtained data, the following types of pharmacoeconomical analysis were performed: calculation of the course price, the cost/effectiveness ratio, and the availability coefficient. …”
Get full text

Risk management strategy for preventing the reduced treatment effectiveness from the position of drug interactions and polypharmacy in patients with coronary heart disease by Anna A. Gruzdeva, Alexander L. Khokhlov, Mikhail V. Ilyin

“…The choice of management measures should be determined considering all the areas of personalized medicine, including pharmacogenetic predictors, pharmacoepidemiological data, pharmacoeconomic effectiveness, the development of adverse reactions, polypragmasia, and medical and social risk factors.…”
Get full text

Cost-Effectiveness of an Obesity Management Program for 6- to 15-Year-Old Children in Poland: Data from Over Three Thousand Participants by Ewa Bandurska, Michał Brzeziński, Paulina Metelska, Marzena Zarzeczna-Baran

“…Objective: The objective of the present study was to evaluate cost-effectiveness of the 6-10-14 for Health weight management program using pharmacoeconomic indicators, i.e., cost-effectiveness analysis using the incremental cost-effectiveness ratio. …”
Get full text

Unita di consumo dei farmaci e valutazioni farmacoeconomiche: uso e misuso di DDD e PDD by Mario Eandi

“…In pharmacoeconomical evaluations the quantification of drug utilization has to be done on the basis of measurement units that allow comparisons among series of longitudinal and transversal data. …”
Get full text

The Problem of Drug Interactions Between Rosuvastatin and Ticagrelor in the Aspect of the Risk of Rhabdomyolysis: Discussion of the Problem and Description of the Clinical Case by O. V. Gaisenok, Yu. M. Chichkov, M. V. Leonova

Get full text

Percorsi diagnostico-terapeutici nella gestione dei pazienti affetti da polmonite acquisita in comunità by Mario Eandi

“…The results of the present review can be used as a background to implement a general decision model suitable to performe pharmacoeconomic analysis of the CAP therapy.…”
Get full text

Multiresistant bacteria and current therapy - the economical side of the story by Wilke MH

“…However, most analyses are based on pharmacoeconomic modelling rather than on directly analysing trial data or real life clinical populations.…”
Get full text

Pharmaco-economic ABC/VEN analysis of pre-hospital hypertensive crise treatment by S. V. Mal’chikova, E. I. Tarlovskaya

“…To analyse the pre-hospital treatment of uncomplicated hypertensive crises (HC), using complex pharmacoeconomic approach. Material and methods. A retrospective study based on the data from ambulance visits to the Kirov City patients with uncomplicated HC. …”
Get full text

Histological research of hepatoprotective activity of tablets Lavaflam in rats with subchronic hepatitis by M. A. Aslanian, L. A. Bobrytska, N. L. Bereznyakova, O. S. Shpychak, V. I. Hrytsenko, T. A. Germanyuk, T. I. Ivko

“…Important issue is the development of a new complex of herbal medicine and its pharmacoeconomic study. The purpose of the work was an experimental substantiation of the hepatoprotective properties of the drug Lavaflam. …”
Get full text

Cost-utility analysis of antihypertensive medications in Nigeria: a decision analysis by Ekwunife Obinna Ikechukwu, Okafor Charles E, Ezenduka Charles C, Udeogaranya Patrick O

“…<p>Abstract</p> <p>Background</p> <p>Many drugs are available for control of hypertension and its sequels in Nigeria but some are not affordable for majority of the populace. This serious pharmacoeconomic question has to be answered by the nation’s health economists. …”
Get full text

Descriptive analysis of work and trends in anaesthesiology from 2005 to 2006: Quantitative and qualitative aspects of effects and evaluation of anaesthesia by Aleksić Valentina V., Simić Snežana, Milaković Branko D., Vučović Dragan S., Majstorović Branislava M.

“…It is important to implement pharmacoeconomic studies in all departments, and to separate the anaesthesia services for emergency and planned operations. …”
Get full text

A cost-minimization analysis of tissue-engineered constructs for corneal endothelial transplantation. by Tien-En Tan, Gary S L Peh, Benjamin L George, Howard Y Cajucom-Uy, Di Dong, Eric A Finkelstein, Jodhbir S Mehta

“…Tissue-engineering strategies for corneal epithelial constructs or other tissue types, such as pancreatic islet cells, should also be subject to similar pharmacoeconomic analyses.…”
Get full text

Cost Utility Analysis Vildagliptin dan Glimepiride dalam Mencegah Komplikasi Mikrovaskuler menggunakan Model Markov by Tri Julia Purnamasari, Stella Ilone, Didik Setiawan

“…This research is a pharmacoeconomic study that uses the Markov Model to compare costs and utilities in type 2 DM patients who receive metformin+glimepiride and metformin+vildagliptin therapy. …”
Get full text

Cost per Number Needed to Treat (NNT) for upadacitinib in the treatment of bio-exposed patients with moderately-severely active ulcerative rectocolitis by Flavio Caprioli, Massimo Claudio Fantini, Francesca Marando, Dario Scaduto, Roberto Ravasio

“…According to the NMA results, the analysis was conducted considering two different timepoints: induction and maintenance. The pharmacoeconomic comparison between advanced therapies was carried out to estimate the respective cost for the NNT (Number Needed to Treat) compared to placebo using the clinical response (CRes) for the induction and clinical remission (CRem) and endoscopic improvement (EI) for the maintenance. …”
Get full text